এই ওষুধে সাশ্রয় করুন
একই সক্রিয় উপাদানের অন্যান্য ব্র্যান্ড
এই ব্র্যান্ডগুলোতে একই সক্রিয় উপাদান আছে (Dotinurad). একই মাত্রা ও ধরন। বদলানোর আগে আপনার ডাক্তার বা ফার্মাসিস্টের সাথে নিশ্চিত হয়ে নিন।
ইঙ্গিত ও ব্যবহার
Dotirad 2 Tablet এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
The usual adult dosage is 0.5 mg of Dotinurad, administered orally once daily. After that, gradually increase the dose as necessary while checking the blood uric acid level. The maintenance dose is usually 2 mg once a day and the dose may be adjusted according to the patient's condition but the maximum dose should be 4 mg once a day.Precautions Related to Dosage and Administration: In the early stages of treatment with urate-lowering drugs, gouty arthritis (gout attack) may be induced by a rapid decrease in blood uric acid levels. The dose should be gradually increased to 1 mg once a day after 2 weeks and 2 mg once a day after 6 weeks. Patients should be carefully monitored after the dose is increased.Missing dose: If you miss a dose, take the missed dose as soon as possible when you remember. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Never take two doses at once. Do not stop taking this medicine without your doctor's advice.Overdose: If you accidentally take too much, consult your doctor or pharmacist.
পার্শ্বপ্রতিক্রিয়া
The most commonly reported side effects gouty arthritis, limb discomfort (1% to less than 5%). (Loose stools, increased y-GTP, arthralgia, kidney stones, nephrocalcinosis, increased urinary y2 macroglobulin, increased blood creatinine, increased urine albumin/creatinine ratio, positive urine albumin) has been reported in less than 1% patients.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Gouty Arthritis: Dotinor is a uric acid-lowering drug and lowering the blood uric acid level at the onset of gouty arthritis (gouty attack) may exacerbate gouty arthritis (gouty attack). If gouty arthritis (gout attack) is observed before administration of Dotinor, administration of Dotinor should not be started until the symptoms subside. In addition, if gouty arthritis (gouty attack) occurs during administration of Dotinor, administration should be continued without changing the dose of Dotinor and colchicine, non-steroidal anti-inflammatory drugs, corticosteroids etc. may be administered depending on the symptoms. Use together.Patients with urolithiasis: Do not administer unless it is judged to be unavoidable for treatment. The pharmacological action of Dotinor may exacerbate the symptoms of urinary calculi due to increased urinary uric acid excretion.Patients with renal impairment: Consider treatment with other agents. Since Dotinor acts in the renal proximal tubule, its efficacy may be reduced depending on the degree of renal dysfunction. In particular, administration of Dotinor should be avoided in patients with oliguria or anuria, as its efficacy cannot be expected.Patients with hepatic impairment: Careful follow-up should be performed. Serious liver damage has been observed with other uricosuric agents.
নিষেধাজ্ঞা
Dotinurad is contraindicated in patients with known hypersensitivity to the drug component.